Taiwan · Delayed Price · Currency is TWD Winston Medical Supply Statistics
Total Valuation
TPEX:6817 has a market cap or net worth of TWD 992.68 million. The enterprise value is 711.27 million.
| Market Cap | 992.68M |
| Enterprise Value | 711.27M |
Important Dates
The last earnings date was Friday, August 7, 2026.
| Earnings Date | Aug 7, 2026 |
| Ex-Dividend Date | Jun 16, 2026 |
Share Statistics
TPEX:6817 has 18.42 million shares outstanding. The number of shares has decreased by -0.24% in one year.
| Current Share Class | 18.42M |
| Shares Outstanding | 18.42M |
| Shares Change (YoY) | -0.24% |
| Shares Change (QoQ) | +0.23% |
| Owned by Insiders (%) | 2.33% |
| Owned by Institutions (%) | n/a |
| Float | 7.53M |
Valuation Ratios
The trailing PE ratio is 12.05.
| PE Ratio | 12.05 |
| Forward PE | n/a |
| PS Ratio | 1.57 |
| PB Ratio | 2.70 |
| P/TBV Ratio | 2.72 |
| P/FCF Ratio | 9.39 |
| P/OCF Ratio | 8.32 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 5.78, with an EV/FCF ratio of 6.73.
| EV / Earnings | 8.63 |
| EV / Sales | 1.12 |
| EV / EBITDA | 5.78 |
| EV / EBIT | 7.29 |
| EV / FCF | 6.73 |
Financial Position
The company has a current ratio of 1.68, with a Debt / Equity ratio of 0.12.
| Current Ratio | 1.68 |
| Quick Ratio | 1.24 |
| Debt / Equity | 0.12 |
| Debt / EBITDA | 0.36 |
| Debt / FCF | 0.42 |
| Interest Coverage | 85.27 |
Financial Efficiency
Return on equity (ROE) is 22.17% and return on invested capital (ROIC) is 90.46%.
| Return on Equity (ROE) | 22.17% |
| Return on Assets (ROA) | 7.45% |
| Return on Invested Capital (ROIC) | 90.46% |
| Return on Capital Employed (ROCE) | 23.55% |
| Weighted Average Cost of Capital (WACC) | 5.00% |
| Revenue Per Employee | 3.52M |
| Profits Per Employee | 458,139 |
| Employee Count | 180 |
| Asset Turnover | 0.77 |
| Inventory Turnover | 2.48 |
Taxes
In the past 12 months, TPEX:6817 has paid 21.25 million in taxes.
| Income Tax | 21.25M |
| Effective Tax Rate | 20.49% |
Stock Price Statistics
The stock price has decreased by -56.36% in the last 52 weeks. The beta is 0.16, so TPEX:6817's price volatility has been lower than the market average.
| Beta (5Y) | 0.16 |
| 52-Week Price Change | -56.36% |
| 50-Day Moving Average | 56.90 |
| 200-Day Moving Average | 76.02 |
| Relative Strength Index (RSI) | 20.96 |
| Average Volume (20 Days) | 26,312 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, TPEX:6817 had revenue of TWD 632.80 million and earned 82.47 million in profits. Earnings per share was 4.47.
| Revenue | 632.80M |
| Gross Profit | 254.45M |
| Operating Income | 97.55M |
| Pretax Income | 103.72M |
| Net Income | 82.47M |
| EBITDA | 119.94M |
| EBIT | 97.55M |
| Earnings Per Share (EPS) | 4.47 |
Balance Sheet
The company has 325.77 million in cash and 44.36 million in debt, with a net cash position of 281.41 million or 15.28 per share.
| Cash & Cash Equivalents | 325.77M |
| Total Debt | 44.36M |
| Net Cash | 281.41M |
| Net Cash Per Share | 15.28 |
| Equity (Book Value) | 367.15M |
| Book Value Per Share | 19.94 |
| Working Capital | 248.43M |
Cash Flow
In the last 12 months, operating cash flow was 119.25 million and capital expenditures -13.53 million, giving a free cash flow of 105.72 million.
| Operating Cash Flow | 119.25M |
| Capital Expenditures | -13.53M |
| Depreciation & Amortization | 22.38M |
| Net Borrowing | -7.93M |
| Free Cash Flow | 105.72M |
| FCF Per Share | 5.74 |
Margins
Gross margin is 40.21%, with operating and profit margins of 15.42% and 13.03%.
| Gross Margin | 40.21% |
| Operating Margin | 15.42% |
| Pretax Margin | 16.39% |
| Profit Margin | 13.03% |
| EBITDA Margin | 18.95% |
| EBIT Margin | 15.42% |
| FCF Margin | 16.71% |
Dividends & Yields
This stock pays an annual dividend of 5.00, which amounts to a dividend yield of 10.20%.
| Dividend Per Share | 5.00 |
| Dividend Yield | 10.20% |
| Dividend Growth (YoY) | -28.57% |
| Years of Dividend Growth | 4 |
| Payout Ratio | 156.33% |
| Buyback Yield | 0.24% |
| Shareholder Yield | 10.24% |
| Earnings Yield | 8.31% |
| FCF Yield | 10.65% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 6 |